• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

沙利度胺对肢体的致畸作用。

The teratogenic effects of thalidomide on limbs.

作者信息

Vargesson Neil

机构信息

School of Medicine, Medical Sciences and Nutrition, University of Aberdeen, Aberdeen, UK.

出版信息

J Hand Surg Eur Vol. 2019 Jan;44(1):88-95. doi: 10.1177/1753193418805249. Epub 2018 Oct 18.

DOI:10.1177/1753193418805249
PMID:30335598
Abstract

Thalidomide remains notorious as a result of the damage it caused to children born to mothers who used it to treat morning sickness between 1957 and 1961. The re-emergence of the drug to treat a range of conditions including erythema nodosum leprosum (a complication of leprosy) has led to a new generation of thalidomide damaged children being born in Brazil. Although thalidomide affects most of the developing tissues and organs of the body, the damage to the limbs is striking. Indeed phocomelia, the severe reduction or loss of the proximal long bones with retention of the distal hand/foot plate remains the stereotypical image of thalidomide. This review focuses on the type and range of damage thalidomide caused to the limbs, reviews current understanding of the mechanisms underlying thalidomide-induced limb malformations and outlines some of the challenges remaining in elucidating its teratogenicity.

摘要

由于在1957年至1961年间,沙利度胺被用于治疗孕吐,导致服用该药物的母亲所生的孩子受到损害,它至今仍臭名昭著。如今,沙利度胺再度出现,被用于治疗包括麻风结节性红斑(麻风病的一种并发症)在内的一系列病症,这导致巴西又出现了新一代因沙利度胺而身体受损的儿童。尽管沙利度胺会影响身体大部分正在发育的组织和器官,但对四肢的损害尤为明显。事实上,海豹肢症,即近端长骨严重缩短或缺失,而远端手足板保留,仍然是沙利度胺造成损害的典型形象。本综述重点关注沙利度胺对四肢造成的损害类型和范围,回顾目前对沙利度胺所致肢体畸形潜在机制的理解,并概述在阐明其致畸性方面仍存在的一些挑战。

相似文献

1
The teratogenic effects of thalidomide on limbs.沙利度胺对肢体的致畸作用。
J Hand Surg Eur Vol. 2019 Jan;44(1):88-95. doi: 10.1177/1753193418805249. Epub 2018 Oct 18.
2
Thalidomide-induced teratogenesis: history and mechanisms.沙利度胺诱导的致畸作用:历史与机制
Birth Defects Res C Embryo Today. 2015 Jun;105(2):140-56. doi: 10.1002/bdrc.21096. Epub 2015 Jun 4.
3
[Thalidomide epidemics: 50 years after].[沙利度胺流行:50年后]
Cas Lek Cesk. 2012;151(12):579-81.
4
Deciphering the mystery of thalidomide teratogenicity.解读沙利度胺致畸性的奥秘。
Congenit Anom (Kyoto). 2012 Mar;52(1):1-7. doi: 10.1111/j.1741-4520.2011.00351.x.
5
The Molecular Mechanisms of Thalidomide Teratogenicity and Implications for Modern Medicine.沙利度胺致畸性的分子机制及其对现代医学的启示
Curr Mol Med. 2017;17(2):108-117. doi: 10.2174/1566524017666170331162315.
6
CPS49-induced neurotoxicity does not cause limb patterning anomalies in developing chicken embryos.CPS49诱导的神经毒性不会在发育中的鸡胚中导致肢体模式异常。
J Anat. 2018 Apr;232(4):568-574. doi: 10.1111/joa.12712. Epub 2017 Oct 10.
7
A clinical review and introduction of the diagnostic algorithm for thalidomide embryopathy (DATE).沙利度胺胚胎病(DATE)诊断算法的临床综述与介绍
J Hand Surg Eur Vol. 2019 Jan;44(1):96-108. doi: 10.1177/1753193418800631. Epub 2018 Sep 25.
8
Longitudinal limb deficiencies and the sclerotomes. An analysis of 378 dysmelic malformations induced by thalidomide.肢体纵向缺损与体节。对378例沙利度胺诱发的肢体发育异常畸形的分析。
J Bone Joint Surg Br. 1999 Jan;81(1):9-23. doi: 10.1302/0301-620x.81b1.8448.
9
Thalidomide-induced limb defects: resolving a 50-year-old puzzle.沙利度胺导致的肢体缺陷:解开一个 50 年的谜题。
Bioessays. 2009 Dec;31(12):1327-36. doi: 10.1002/bies.200900103.
10
[The thalidomide experience: review of its effects 50 years later].[沙利度胺事件:50年后对其影响的回顾]
Med Clin (Barc). 2012 Jun 2;139(1):25-32. doi: 10.1016/j.medcli.2011.10.011. Epub 2011 Dec 15.

引用本文的文献

1
Targeting neuroinflammation: 3-monothiopomalidomide a new drug candidate to mitigate traumatic brain injury and neurodegeneration.靶向神经炎症:3-单硫代泊马度胺——一种减轻创伤性脑损伤和神经退行性变的新型候选药物。
J Biomed Sci. 2025 Jun 16;32(1):57. doi: 10.1186/s12929-025-01150-w.
2
Unveiling the effects of micro and nano plastics in embryonic development.揭示微塑料和纳米塑料对胚胎发育的影响。
Toxicol Rep. 2025 Feb 19;14:101954. doi: 10.1016/j.toxrep.2025.101954. eCollection 2025 Jun.
3
Breaking the final barrier: Evolution of cationic and ionizable lipid structure in lipid nanoparticles to escape the endosome.
打破最后的障碍:脂质纳米粒中阳离子和离子化脂质结构的进化以逃避内涵体。
Adv Drug Deliv Rev. 2024 Nov;214:115446. doi: 10.1016/j.addr.2024.115446. Epub 2024 Sep 16.
4
Limb reduction in an Esco2 cohesinopathy mouse model is mediated by p53-dependent apoptosis and vascular disruption.Esco2 黏连蛋白病小鼠模型中的肢体缺失是由 p53 依赖性细胞凋亡和血管破坏介导的。
Nat Commun. 2024 Aug 21;15(1):7154. doi: 10.1038/s41467-024-51328-3.
5
Insights into digit evolution from a fate map study of the forearm using Chameleon, a new transgenic chicken line.利用新型转基因鸡品系 Chameleon 对手前臂的命运图谱研究获得的有关数字进化的见解。
Development. 2024 Jul 1;151(13). doi: 10.1242/dev.202340. Epub 2024 Jun 28.
6
The role of E3 ubiquitin ligases in bone homeostasis and related diseases.E3泛素连接酶在骨稳态及相关疾病中的作用。
Acta Pharm Sin B. 2023 Oct;13(10):3963-3987. doi: 10.1016/j.apsb.2023.06.016. Epub 2023 Jul 6.
7
Transcriptome-based prediction of drugs, inhibiting cardiomyogenesis in human induced pluripotent stem cells.基于转录组学预测抑制人诱导多能干细胞心肌生成的药物。
Cell Death Discov. 2023 Aug 29;9(1):321. doi: 10.1038/s41420-023-01616-6.
8
A New Strategy for the Old Challenge of Thalidomide: Systems Biology Prioritization of Potential Immunomodulatory Drug (IMiD)-Targeted Transcription Factors.沙利度胺旧挑战的新策略:潜在免疫调节药物(IMiD)靶向转录因子的系统生物学优先级划分。
Int J Mol Sci. 2023 Jul 15;24(14):11515. doi: 10.3390/ijms241411515.
9
Repurposing of Chronically Used Drugs in Cancer Therapy: A Chance to Grasp.长期使用药物在癌症治疗中的重新利用:一个值得把握的机会。
Cancers (Basel). 2023 Jun 15;15(12):3199. doi: 10.3390/cancers15123199.
10
A New Generation of IMiDs as Treatments for Neuroinflammatory and Neurodegenerative Disorders.新一代 IMiDs 类药物治疗神经炎症和神经退行性疾病。
Biomolecules. 2023 Apr 26;13(5):747. doi: 10.3390/biom13050747.